Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders
Related Experiment Video
Updated: Apr 24, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
1Northern Sydney Drug and Alcohol Service, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Abstract:
Wernicke encephalopathy is an acute, reversible neuropsychiatric emergency due to thiamine deficiency. Urgent and adequate thiamine replacement is necessary to avoid death or progression to Korsakoff syndrome with largely irreversible brain damage. Wernicke Korsakoff syndrome refers to a condition where features of Wernicke encephalopathy are mixed with those of Korsakoff syndrome. Although thiamine is the cornerstone of treatment of Wernicke encephalopathy, there are no universally accepted guidelines with regard to its optimal dose, mode of administration, frequency of administration or duration of treatment. Currently, different dose recommendations are being made. We present recommendations for the assessment and treatment of Wernicke encephalopathy based on literature review and our clinical experience.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
Hepatic Encephalopathy
CNS Depressants: Alcohol and Nicotine
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Pharmaceutical Poisoning: Treatment Strategies

